MRVI
Maravai Lifesciences Holdings IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.28B
P/E Ratio
—
EPS
$-0.90
Beta
0.43
52W High
$4.11
52W Low
$1.95
50-Day MA
$3.27
200-Day MA
$3.14
Dividend Yield
—
Profit Margin
-70.40%
Forward P/E
370.37
PEG Ratio
—
About Maravai Lifesciences Holdings Inc
Maravai LifeSciences Holdings, Inc., a life sciences company, offers products to enable the development of drug therapies, diagnostics, novel vaccines, and to support human disease research in the United States and internationally. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $185.74M |
| Gross Profit (TTM) | $35.69M |
| EBITDA | $-74.12M |
| Operating Margin | -39.40% |
| Return on Equity | -48.60% |
| Return on Assets | -8.83% |
| Revenue/Share (TTM) | $1.29 |
| Book Value | $1.46 |
| Price-to-Book | 2.42 |
| Price-to-Sales (TTM) | 6.91 |
| EV/Revenue | 3.559 |
| EV/EBITDA | 1.77 |
| Quarterly Earnings Growth (YoY) | -32.70% |
| Quarterly Revenue Growth (YoY) | -11.80% |
| Shares Outstanding | $147.50M |
| Float | $98.06M |
| % Insiders | 11.72% |
| % Institutions | 89.92% |
Historical Volatility
HV 10-Day
61.00%
HV 20-Day
59.98%
HV 30-Day
56.76%
HV 60-Day
55.71%
HV Rank
19.8%
Volatility is currently expanding
Analyst Ratings
Consensus ($4.60 target)
5
Buy5
HoldData last updated: 4/30/2026